SKI Market

Indian Indices

Sensex

78,918.90 -1,097.00
( -1.37%)

Global Indices

Nasdaq

47,963.68 -796.74
(-1.63%)

Dow Jones

6,850.98 -39.52
(-0.57%)

Hang Seng

55,600.46 322.40
(0.58%)

Nikkei 225

10,430.91 -136.74
(-1.29%)

Forex

USD-INR

92.13 0.17
(0.19%)

EUR-INR

107.06 0.12
(0.11%)

GBP-INR

123.03 0.33
(0.27%)

JPY-INR

0.59 0.00
(0.39%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532531

INE939A01011

344.5797109

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

STAR

42.75

7840.67

EPS(TTM)

Face Value()

Div & Yield %

19.9

0.47

Back

Alankit consolidated net profit rises 37.46% in the September 2025 quarter

Nov 13,2025

Net profit of Alankit rose 37.46% to Rs 4.33 crore in the quarter ended September 2025 as against Rs 3.15 crore during the previous quarter ended September 2024. Sales rose 24.46% to Rs 80.09 crore in the quarter ended September 2025 as against Rs 64.35 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	80.09	64.35	24
OPM %	4.27	8.41	-
PBDT	8.16	8.31	-2
PBT	4.85	6.15	-21
NP	4.33	3.15	37

78,918.90 -1,097.00 ( -1.37%)

47,963.68 -796.74 (-1.63%)

6,850.98 -39.52 (-0.57%)

55,600.46 322.40 (0.58%)

10,430.91 -136.74 (-1.29%)

92.13 0.17 (0.19%)

107.06 0.12 (0.11%)

123.03 0.33 (0.27%)

0.59 0.00 (0.39%)